Skip to record

Executive record

Michal Votruba, M.D.

Director at BioXcel Therapeutics, Inc.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:michal-votruba-m-dVersion: public-0As of: 2026-10-03

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Dr. Michal Votruba has been a Director of the Gradus/RSJ Life Sciences Fund since 2013, the largest dedicated fund in Central Europe. He served as a clinical psychiatrist and has over eight years of experience as an industry analyst providing competitive intelligence to senior leaders at major pharmaceutical companies including Amgen, Novartis, Eli Lilly, and Allergan. He also serves on the boards of PrimeCell Therapeutics and Telemynd, Inc.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.